Webinar: Clinical Trials, PV and the Future. A Live Conversation with Dr. Susanne Isfort and Silence Therapeutics
- Peter Löffelhardt
- 11 hours ago
- 2 min read
Following the success of our first webinar with Silence Therapeutics, we are excited to announce the second session of this meeting. This time, we continue on Silence Therapeutics and their investigational therapy for Polycythemia Vera (PV), alongside a unique opportunity to ask your general questions about clinical trials directly to an MPN expert.
Join us on August 28 at 18:00 CEST for this exclusive webinar in English, with live interpretation into Spanish.
Content guide
What to Expect?
This session will include:
Dr. Susanne Isfort, MD (Hematologist, clinical researcher and MPN expert, Germany)Dr. Isfort will answer general questions about clinical trials: how they work, what to expect, and what every patient should know before participating.
Alberto Martinez (Senior Director of Clinical Science at Silence Therapeutics)He will continue explaining divesiran, a treatment in development for PV, and explain how Silence is advancing innovative therapies for MPNs.
You’ll also hear from young patients living with PV, sharing their doubts before joining a trial, their first impressions, and the importance of sharing patient perspectives.
About Silence Therapeutics
Silence Therapeutics is a UK-based biotech company developing precision RNA-based therapies. With ongoing work in hematology, they are committed to changing outcomes for patients with MPNs through global research and clinical innovation.
Webinar Details
Date: Thursday, August 28
Time: 18:00 CEST
Language: English with simultaneous interpretation in Spanish
Open to: Patients, caregivers, healthcare professionals, and advocates
Format: Online and free via Zoom
Let’s continue building bridges between patients, physicians and pharmaceutical partners (3P’s). This event is part of our ongoing commitment to bring clarity and connection to the MPN community.
Comments